Philip Ashman's most recent trade in Alimera Sciences Inc. was a trade of 12,103 Common Stock done at an average price of $3.8 . Disclosure was reported to the exchange on March 26, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alimera Sciences Inc. | Philip Ashman | President of Intl Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.83 per share. | 26 Mar 2024 | 12,103 | 118,274 (2%) | 0% | 3.8 | 46,354 | Common Stock |
| Alimera Sciences Inc. | Philip Ashman | President of Intl Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 75,000 | 75,000 | - | - | Performance-Based Restricted Stock Units | |
| Alimera Sciences Inc. | Philip Ashman | President of Intl Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 6,800 | 6,800 | - | - | Restricted Stock Units | |
| Alimera Sciences Inc. | Philip Ashman | President of Intl Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.86 per share. | 10 Jan 2024 | 2,938 | 130,377 (2%) | 0% | 3.9 | 11,344 | Common Stock |
| Alimera Sciences Inc. | Philip Ashman | Chief Operating Officer & SVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2023 | 103,000 | 133,315 (2%) | 2% | 0 | Common Stock | |
| Alimera Sciences Inc. | Philip Ashman | Chief Operating Officer & SVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.81 per share. | 03 Feb 2023 | 2,889 | 30,315 (0%) | 0% | 2.8 | 8,119 | Common Stock |
| Alimera Sciences Inc. | Philip Ashman | Chief Operating Officer & SVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.65 per share. | 10 Jan 2022 | 1,175 | 33,204 (0%) | 0% | 4.7 | 5,464 | Common Stock |
| Alimera Sciences Inc. | Philip Ashman | Chief Operating Officer & SVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 45,000 | 45,000 | - | - | Employee Stock Option (Right to Buy) | |
| Alimera Sciences Inc. | Philip Ashman | Chief Operating Officer & SVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 15,000 | 34,379 (0%) | 0% | 0 | Common Stock | |
| Alimera Sciences Inc. | Philip Ashman | Chief Operating Officer & SVP | Sale of securities on an exchange or to another person at price $ 9.62 per share. | 08 Apr 2021 | 45 | 19,379 (0%) | 0% | 9.6 | 433 | Common Stock |
| Alimera Sciences Inc. | Philip Ashman | Chief Operating Officer & SVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.77 per share. | 04 Mar 2021 | 2,533 | 19,424 (0%) | 0% | 7.8 | 19,681 | Common Stock |
| Alimera Sciences Inc. | Philip Ashman | Chief Operating Officer & SVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 30,000 | 30,000 | - | - | Employee Stock Option (Right to Buy) | |
| Alimera Sciences Inc. | Philip Ashman | Chief Operating Officer & SVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 10,000 | 21,957 (0%) | 0% | 0 | Common Stock | |
| Alimera Sciences Inc. | Philip Ashman | Chief Operating Officer & SVP | Purchase of securities on an exchange or from another person at price $ 4.50 per share. | 04 Nov 2020 | 1,316 | 11,957 (0%) | 0% | 4.5 | 5,922 | Common Stock |